NCT05703620View on ClinicalTrials.gov

REducing Sympathetic Activity Through Ultrasound-based Renal deneRvation in Excessive Cardiovascular Risk populaTions.

NARecruitingINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

October 8, 2021

Primary Completion Date

May 18, 2025

Study Completion Date

May 18, 2026

Conditions
Chronic Kidney DiseasesHeart FailureEnd Stage Renal Disease
Interventions
DEVICE

Renal Denervation

All eligible participants receive ultrasound based renal denervation to both kidneys on all eligible vessels

Trial Locations (1)

6000

RECRUITING

Royal Perth Hospital, Perth

All Listed Sponsors
collaborator

ReCor Medical, Inc.

INDUSTRY

lead

Royal Perth Hospital

OTHER